Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro.

Sun X, Han F, Yi J, Hou N, Cao Z.

Mol Med Rep. 2013 May;7(5):1636-40. doi: 10.3892/mmr.2013.1350. Epub 2013 Feb 28.

PMID:
23450462
2.

Evidence for telomerase activation in VSMCs exposed to hyperglycemic and hyperhomocysteinemic conditions.

Jacob T, Hingorani A, Ascher E.

Angiology. 2009 Oct-Nov;60(5):562-8. doi: 10.1177/0003319709332956. Epub 2009 Apr 26.

PMID:
19398425
3.

Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation.

Wang S, Li Y.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2075-83. doi: 10.1152/ajpheart.00521.2009. Epub 2009 Aug 28. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2075.

4.

Role of oxidative stress in high glucose-induced decreased expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells.

Li Y, Descorbeth M, Anand-Srivastava MB.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2845-54. doi: 10.1152/ajpheart.91422.2007. Epub 2008 Apr 25.

5.
6.

The additive effects of glucose and insulin on the proliferation of infragenicular vascular smooth muscle cells.

Avena R, Mitchell ME, Neville RF, Sidawy AN.

J Vasc Surg. 1998 Dec;28(6):1033-8; discussion 1038-9.

7.

Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin.

Sun J, Xu Y, Dai Z, Sun Y.

Mol Cell Endocrinol. 2009 Dec 10;313(1-2):64-9. doi: 10.1016/j.mce.2009.08.019. Epub 2009 Aug 31.

PMID:
19723557
8.

High glucose increases the expression of Gq/11alpha and PLC-beta proteins and associated signaling in vascular smooth muscle cells.

Descorbeth M, Anand-Srivastava MB.

Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2135-42. doi: 10.1152/ajpheart.00704.2008. Epub 2008 Sep 26.

9.

C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.

Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, GrĂ¼b M, Hombach V, Strong J, Marx N.

Circ Res. 2006 Nov 24;99(11):1181-7. Epub 2006 Oct 26.

10.

Regulation of SIRT1 in vascular smooth muscle cells from streptozotocin-diabetic rats.

Toniolo A, Warden EA, Nassi A, Cignarella A, Bolego C.

PLoS One. 2013 May 29;8(5):e65666. doi: 10.1371/journal.pone.0065666. Print 2013.

11.

Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats.

Tsihlis ND, Rodriguez MP, Jiang Q, Schwartz A, Flynn ME, Vercammen JM, Kibbe MR.

J Surg Res. 2016 May 15;202(2):413-21. doi: 10.1016/j.jss.2016.01.030. Epub 2016 Jan 30.

12.

Progesterone inhibits human infragenicular arterial smooth muscle cell proliferation induced by high glucose and insulin concentrations.

Carmody BJ, Arora S, Wakefield MC, Weber M, Fox CJ, Sidawy AN.

J Vasc Surg. 2002 Oct;36(4):833-8.

13.

Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.

Shen X, Li H, Li W, Wu X, Ding X.

Mol Cell Endocrinol. 2012 Nov 5;363(1-2):27-35. doi: 10.1016/j.mce.2012.07.005. Epub 2012 Jul 17.

PMID:
22820128
14.

Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.

Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, Bennett M.

Circ Res. 2006 Jul 21;99(2):156-64. Epub 2006 Jun 22.

15.

The effect of cotinine on telomerase activity in human vascular smooth muscle cells.

Jacob T, Clouden N, Hingorani A, Ascher E.

J Cardiovasc Surg (Torino). 2009 Jun;50(3):345-9. Epub 2009 Apr 1.

PMID:
19339962
16.

Effects of serum of streptozotocin-induced diabetic rats on vascular smooth muscle cell growth in vitro.

Wang R, Kudo M, Naito Z, Yokoyama M, Yamada N, Asano G.

Nihon Ika Daigaku Zasshi. 1998 Aug;65(4):284-90.

PMID:
9755596
17.

Activation of smooth muscle cell outgrowth from BB/Wor rat aortas.

Larson DM, Haudenschild CC.

Diabetes. 1988 Oct;37(10):1380-5.

PMID:
3046969
18.

Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice.

Reddy MA, Villeneuve LM, Wang M, Lanting L, Natarajan R.

Circ Res. 2008 Sep 12;103(6):615-23. doi: 10.1161/CIRCRESAHA.108.175190. Epub 2008 Aug 7. Retraction in: Circ Res. 2009 Sep 11;105(6):e9.

19.

Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.

Kim SY, Jeoung NH, Oh CJ, Choi YK, Lee HJ, Kim HJ, Kim JY, Hwang JH, Tadi S, Yim YH, Lee KU, Park KG, Huh S, Min KN, Jeong KH, Park MG, Kwak TH, Kweon GR, Inukai K, Shong M, Lee IK.

Circ Res. 2009 Apr 10;104(7):842-50. doi: 10.1161/CIRCRESAHA.108.189837. Epub 2009 Feb 19.

20.

Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.

Torella D, Gasparri C, Ellison GM, Curcio A, Leone A, Vicinanza C, Galuppo V, Mendicino I, Sacco W, Aquila I, Surace FC, Luposella M, Stillo G, Agosti V, Cosentino C, Avvedimento EV, Indolfi C.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2015-25. doi: 10.1152/ajpheart.00738.2009. Epub 2009 Sep 25.

Supplemental Content

Support Center